The company has increased its payouts over the past five years despite significant challenges.

By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...

One analyst reiterated his pessimistic view of the pharmaceutical titan's future.

Poland and Romania have been ordered by a Belgian court to pay Pfizer Inc. €1.9 billion ($2.2 billion) for Covid-19 vaccines ...

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, a lackluster result as fewer-than-expected infections in the pivotal study made its potency ...

The healthcare stock looks ridiculously undervalued.

The news is the latest example of the biotech industry's struggles in the Bay Area.

Good news has been scarce for this beaten-down drugmaker.

Pfizer has emerged victorious in a legal brawl with Poland and Romania over contested COVID vaccine orders, with a Belgian ...

Doctors break down what you need to know about the four-dose vaccine.

Before deciding to walk away from the building, Pfizer tried to list nearly half of the 164,000-square-foot campus for ...